SK284171B9 - Derivát 4''-substituovaného-9-deoxo-9a-aza-9a-homoerytromycínu A, spôsob a medziprodukty na jeho prípravu, jeho použitie a farmaceutická kompozícia s jeho obsahom - Google Patents

Derivát 4''-substituovaného-9-deoxo-9a-aza-9a-homoerytromycínu A, spôsob a medziprodukty na jeho prípravu, jeho použitie a farmaceutická kompozícia s jeho obsahom

Info

Publication number
SK284171B9
SK284171B9 SK168399A SK168399A SK284171B9 SK 284171 B9 SK284171 B9 SK 284171B9 SK 168399 A SK168399 A SK 168399A SK 168399 A SK168399 A SK 168399A SK 284171 B9 SK284171 B9 SK 284171B9
Authority
SK
Slovakia
Prior art keywords
homoerythromycin
deoxo
aza
intermediates
derivative
Prior art date
Application number
SK168399A
Other languages
English (en)
Slovak (sk)
Other versions
SK168399A3 (en
SK284171B6 (sk
Inventor
Brian Scott Bronk
Michael Anthony Letavic
Takushi Kaneko
Bingwei Vera Yang
Edward Alan Glazer
Hengmiao Cheng
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21959336&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK284171(B9) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of SK168399A3 publication Critical patent/SK168399A3/sk
Publication of SK284171B6 publication Critical patent/SK284171B6/sk
Publication of SK284171B9 publication Critical patent/SK284171B9/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK168399A 1997-06-11 1998-05-29 Derivát 4''-substituovaného-9-deoxo-9a-aza-9a-homoerytromycínu A, spôsob a medziprodukty na jeho prípravu, jeho použitie a farmaceutická kompozícia s jeho obsahom SK284171B9 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4934897P 1997-06-11 1997-06-11
PCT/IB1998/000839 WO1998056802A1 (en) 1997-06-11 1998-05-29 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives

Publications (3)

Publication Number Publication Date
SK168399A3 SK168399A3 (en) 2000-11-07
SK284171B6 SK284171B6 (sk) 2004-10-05
SK284171B9 true SK284171B9 (sk) 2005-03-04

Family

ID=21959336

Family Applications (1)

Application Number Title Priority Date Filing Date
SK168399A SK284171B9 (sk) 1997-06-11 1998-05-29 Derivát 4''-substituovaného-9-deoxo-9a-aza-9a-homoerytromycínu A, spôsob a medziprodukty na jeho prípravu, jeho použitie a farmaceutická kompozícia s jeho obsahom

Country Status (49)

Country Link
US (4) US6420536B1 (https=)
EP (1) EP0988310B9 (https=)
JP (2) JP3315704B2 (https=)
KR (1) KR100396168B1 (https=)
CN (4) CN1793155B (https=)
AP (1) AP1231A (https=)
AR (1) AR013086A1 (https=)
AT (1) ATE251173T1 (https=)
AU (1) AU749816B2 (https=)
BG (1) BG64391B1 (https=)
BR (1) BRPI9810519B8 (https=)
CA (1) CA2293823C (https=)
CO (1) CO4950611A1 (https=)
CZ (1) CZ298556B6 (https=)
DE (2) DE122004000018I2 (https=)
DK (1) DK0988310T3 (https=)
DZ (1) DZ2514A1 (https=)
EA (1) EA002441B1 (https=)
EG (1) EG24081A (https=)
ES (1) ES2205487T3 (https=)
FR (1) FR04C0013I2 (https=)
GT (1) GT199800077A (https=)
HN (1) HN1998000086A (https=)
HR (1) HRP980314B1 (https=)
HU (2) HU228005B1 (https=)
ID (1) ID22992A (https=)
IL (1) IL132809A0 (https=)
IS (1) IS1998B (https=)
LU (1) LU91076I9 (https=)
MA (1) MA24564A1 (https=)
ME (1) ME00876B (https=)
MY (1) MY123354A (https=)
NL (1) NL300150I2 (https=)
NO (1) NO316911B1 (https=)
NZ (2) NZ500660A (https=)
OA (1) OA11224A (https=)
PA (1) PA8452201A1 (https=)
PE (1) PE79699A1 (https=)
PL (1) PL191601B1 (https=)
PT (1) PT988310E (https=)
RS (1) RS49675B (https=)
SI (1) SI0988310T1 (https=)
SK (1) SK284171B9 (https=)
TN (1) TNSN98082A1 (https=)
TW (1) TW472060B (https=)
UA (1) UA67744C2 (https=)
UY (1) UY25040A1 (https=)
WO (1) WO1998056802A1 (https=)
ZA (1) ZA985017B (https=)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
EP1779853A3 (en) * 1997-09-10 2010-01-27 Merial Ltd. 9a-azalides as veterinary antimicrobial agents
ES2281136T3 (es) * 1997-09-10 2007-09-16 Merial Ltd. Uso de 9a-azalidos como agentes antimicrobiales veterinarios.
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
CA2411293A1 (en) * 1999-01-28 2000-07-28 Pfizer Products Inc. Novel azalides and methods of making same
DE60038610T2 (de) * 1999-05-18 2009-06-25 Pfizer Products Inc., Groton Neue kristalline formen eines makrolidantibiotikums
HUP0201516A3 (en) * 1999-05-24 2003-03-28 Pfizer Prod Inc 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
DK1206476T3 (da) * 1999-08-24 2006-05-15 Abbott Lab 9a-azalider med antibakteriel virkning
US6608033B1 (en) 1999-08-27 2003-08-19 Pfizer Inc. Treatment or prevention of coccidiosis
BRPI0017013B1 (pt) 2000-01-27 2015-07-14 Zoetis P Llc Composição de antibiótico azalídeo e método para sua obtenção
BR0110382A (pt) * 2000-04-27 2003-06-24 Pfizer Prod Inc Utilização de composições antibióticas azalida para o tratamento ou prevenção de uma infecção causada por bactérias ou protozoários em mamìferos
RU2263117C2 (ru) * 2001-04-27 2005-10-27 Пфайзер Продактс Инк. Способ получения 4"-замещенных производных 9-деоксо-9а-аза-9а-гомоэритромицина а
AU2002317415A1 (en) * 2001-08-01 2003-02-17 Pfizer Products Inc. Azalide antibiotic compositions
EP1638549A4 (en) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
WO2005030227A1 (en) 2003-09-23 2005-04-07 Enanta Pharmaceuticals, Inc. 9a, 11-3C-BICYCLIC 9a-AZALIDE DERIVATIVES
MXPA06005639A (es) * 2003-11-21 2006-08-17 Pfizer Prod Inc Adyuvante antimicrobiano.
CN103030617A (zh) * 2004-03-16 2013-04-10 贝林格尔.英格海姆国际有限公司 吡喃葡萄糖基取代的苯基衍生物、含该化合物的药物、其用途及其制造方法
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7402568B2 (en) 2004-09-29 2008-07-22 Enanta Pharmaceuticals, Inc. Bicyclic 9a-azalide derivatives
US7767797B1 (en) * 2004-09-30 2010-08-03 Synovo Gmbh Macrocyclic compounds and methods of use thereof
US7271155B2 (en) 2005-01-07 2007-09-18 Enanta Pharmaceuticals, Inc. 9A, 11-2C-bicyclic 9a-azalide derivatives
ATE429921T1 (de) * 2005-01-14 2009-05-15 Glaxosmithkline Zagreb 9a-carbamoyl- und thiocarbamoylazalide mit antimalariawirkung
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
JP5711135B2 (ja) 2008-10-24 2015-04-30 センプラ ファーマシューティカルズ，インコーポレイテッド 胃腸疾患を治療するための方法
US9937194B1 (en) * 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
MX361413B (es) 2010-03-22 2018-12-05 Cempra Pharmaceuticals Inc Star Formas cristalinas de un macrólido y usos para las mismas.
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
WO2012038372A1 (en) 2010-09-20 2012-03-29 Novartis Ag Novel process for the preparation of 9-deoxo-9a-aza- 9a-homoerythromycin a modified in the c-4'' of the cladinose ring by an epoxide group
EP2625185A4 (en) * 2010-10-10 2014-03-26 Synovo Gmbh INFLAMMATORY MAKROLIDE
WO2013004116A1 (zh) * 2011-07-06 2013-01-10 洛阳惠中兽药有限公司 C-3取代的-9-脱氧-9a-氮杂-9a-高红霉素a衍生物
CN102260306B (zh) * 2011-07-22 2012-07-18 山东鲁抗舍里乐药业有限公司 一种制备泰拉霉素的方法
EP2736915A1 (en) 2011-07-27 2014-06-04 Farma GRS, d.o.o. New crystalline forms of tulathromycin
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
CN102786569B (zh) * 2012-09-07 2016-12-07 安徽中升药业有限公司 泰拉霉素中间体及其制备方法与泰拉霉素的制备方法
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法
EP3027634B1 (en) * 2013-07-31 2018-03-21 Farma GRS, d.o.o. Process for preparation of tulathromycin
CN103497227B (zh) * 2013-09-13 2015-09-30 青岛科技大学 一种泰拉菌素中间体的制备方法
CN104725446B (zh) * 2015-03-26 2017-10-27 宁夏泰瑞制药股份有限公司 一种从泰拉霉素粗品中分离泰拉霉素a和泰拉霉素b的方法
CN104861018A (zh) * 2015-06-17 2015-08-26 瑞普（天津）生物药业有限公司 一种泰拉菌素的制备方法
CN105646617A (zh) * 2016-01-21 2016-06-08 杭州海尔希畜牧科技有限公司 一种制备泰拉霉素的方法
FR3048612B1 (fr) * 2016-03-14 2020-10-02 Septeos Tulathromycine potentialisee
CN106046077B (zh) * 2016-08-04 2019-07-26 湖北美天生物科技股份有限公司 一种泰拉霉素a的合成方法
CN108003207B (zh) 2017-12-19 2019-05-10 海门慧聚药业有限公司 制备泰拉霉素的方法
CN111087433B (zh) * 2018-10-23 2023-03-21 湖北美天生物科技股份有限公司 一种泰拉霉素中间体的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5226958A (en) * 1991-04-11 1993-07-13 Pacemark, Inc. Sealant for pneumatic inner tubes and tubeless tires
EP0549040A1 (en) 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
HN1998000086A (es) 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
UA70972C2 (uk) 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
CN1793155A (zh) 2006-06-28
RS49675B (sr) 2007-11-15
US20040180842A1 (en) 2004-09-16
CN1566129A (zh) 2005-01-19
CZ442199A3 (cs) 2000-07-12
HUS1200028I1 (hu) 2016-08-29
KR100396168B1 (ko) 2003-08-27
PL337505A1 (en) 2000-08-28
DZ2514A1 (fr) 2003-02-01
DK0988310T3 (da) 2003-12-15
AP1231A (en) 2003-12-11
US6777393B2 (en) 2004-08-17
HK1028048A1 (en) 2001-02-02
TNSN98082A1 (fr) 2005-03-15
CN1243766C (zh) 2006-03-01
HUP0002209A2 (hu) 2000-12-28
PL191601B1 (pl) 2006-06-30
US6420536B1 (en) 2002-07-16
NO996106L (no) 2000-02-10
DE69818665T2 (de) 2004-04-29
HK1068893A1 (en) 2005-07-29
EA199901015A1 (ru) 2000-06-26
EP0988310B1 (en) 2003-10-01
HK1088014A1 (zh) 2006-10-27
PA8452201A1 (es) 2000-05-24
ATE251173T1 (de) 2003-10-15
AU749816B2 (en) 2002-07-04
AR013086A1 (es) 2000-12-13
EP0988310B9 (en) 2006-03-08
BG64391B1 (bg) 2004-12-30
PE79699A1 (es) 1999-08-25
BRPI9810519B1 (pt) 2012-02-22
NZ500660A (en) 2002-03-01
SI0988310T1 (en) 2004-02-29
UA67744C2 (uk) 2004-07-15
BG103945A (bg) 2000-07-31
CZ298556B6 (cs) 2007-11-07
WO1998056802A1 (en) 1998-12-17
JP2000514098A (ja) 2000-10-24
AU7347598A (en) 1998-12-30
DE69818665D1 (de) 2003-11-06
HRP980314A2 (en) 1999-04-30
BRPI9810519B8 (pt) 2022-11-16
IS1998B (is) 2005-03-15
ZA985017B (en) 1999-12-17
CN101691390A (zh) 2010-04-07
LU91076I2 (fr) 2004-07-05
ME00876B (me) 2012-06-20
CN1172947C (zh) 2004-10-27
BRPI9810519A (pt) 2000-09-19
HN1998000086A (es) 1999-03-08
ES2205487T3 (es) 2004-05-01
NL300150I1 (nl) 2004-08-02
EP0988310A1 (en) 2000-03-29
GT199800077A (es) 1999-12-02
ID22992A (id) 1999-12-23
MY123354A (en) 2006-05-31
JP2002316933A (ja) 2002-10-31
CO4950611A1 (es) 2000-09-01
NO316911B1 (no) 2004-06-21
EA002441B1 (ru) 2002-04-25
JP3315704B2 (ja) 2002-08-19
NL300150I2 (nl) 2004-09-01
DE122004000018I1 (de) 2004-09-30
CN1793155B (zh) 2010-05-12
AP9801255A0 (en) 1998-06-30
NZ514871A (en) 2003-08-29
YU58699A (https=) 2002-08-12
IL132809A0 (en) 2001-03-19
HRP980314B1 (en) 2004-04-30
TW472060B (en) 2002-01-11
KR20010013632A (ko) 2001-02-26
UY25040A1 (es) 2000-09-29
HU228005B1 (en) 2012-08-28
MA24564A1 (fr) 1998-12-31
CA2293823A1 (en) 1998-12-17
US6936592B2 (en) 2005-08-30
US20020061858A1 (en) 2002-05-23
SK168399A3 (en) 2000-11-07
CN1259136A (zh) 2000-07-05
EG24081A (en) 2008-05-11
OA11224A (en) 2003-07-16
IS5252A (is) 1999-11-16
SK284171B6 (sk) 2004-10-05
HUP0002209A3 (en) 2003-05-28
FR04C0013I1 (https=) 2004-06-11
DE122004000018I2 (de) 2011-01-13
NO996106D0 (no) 1999-12-10
US20040023896A1 (en) 2004-02-05
LU91076I9 (en) 2018-07-02
PT988310E (pt) 2003-12-31
CA2293823C (en) 2004-02-17
FR04C0013I2 (https=) 2005-10-21

Similar Documents

Publication Publication Date Title
SK284171B9 (sk) Derivát 4''-substituovaného-9-deoxo-9a-aza-9a-homoerytromycínu A, spôsob a medziprodukty na jeho prípravu, jeho použitie a farmaceutická kompozícia s jeho obsahom
ZA9810490B (en) 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor
FI962754L (fi) Uusia mahdollisesti substituoituja fenyyli-imidatsolidiineja, menetelmä niiden valmistamiseksi sekä valmistuksen välituotteita, niiden käyttö lääkkeinä ja niitä käsittävät farmaseuttiset koostumukset
EE200000319A (et) hGRF-PEG konjugaatide saitspetsiifiline valmistamismeetod, hGRF-PEG konjugaadid, nende vaheühendid, kasutamine ja farmatseutiline kompositsioon
HUP9701169A3 (en) Cycloalkano-pyridine derivatives, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds
HUP0102307A3 (en) Bispidine derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
DE69634053D1 (de) Oral anzuwendende Arzneizusammensetzung enthaltend 2-Methyl-thienobenzodiazepin
FI951681A7 (fi) Substituoidut N-heteroaroyyliguanidiinit, menetelmä niiden valmistamiseksi niiden käyttö lääkeaineina tai diagnostisena aineena sekä niitä sisältävä lääkeaine
FI973518A0 (fi) Farmaseuttinen koostumus piperidinoalkanoliyhdisteille
HUP0004024A3 (en) Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof
HUP9901159A3 (en) Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds
DK0920302T4 (da) Farmaceutisk aerosolsammensætning
IL118426A0 (en) Pharmaceutical composition containing 1,3-bis-triazolyl-2- propanol derivative
NO20041007L (no) Anvendelse av oksypurin-nukleosider for fremstilling av et farmasoytisk preparat
HUP9802393A3 (en) Benzothiazolone derivatives, their use, pharmaceutical compositions containing them, process for the preparation thereof and intermediates
FI953384L (fi) Uusi bentsolitiaditsiiniyhdiste, menetelmä sen valmistamiseksi ja sitä sisältävät farmaseuttiset koostumukset
HUP0002724A3 (en) Clasto-lactacystin betha-lactone, analogs and intermediates thereof, process for their preparation and pharmaceutical compositions containing them
BR9507768A (pt) Composição farmacêutica
FI973229A0 (fi) Uusi farmaseuttinen koostumus
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
NZ291597A (en) Carboxycyclopropan-1-yl derivatives, preparation, pharmaceutical compositions and intermediates thereof
FI964436A7 (fi) Uudet hydroksiimijohdannaiset, niitä sisältävät farmaseuttiset koostumukset sekä menetelmä niiden valmistamiseksi
FI973280A0 (fi) Farmaseuttinen koostumus
FI972129L (fi) 6-metoksi-1H-bentsotriatsoli-5-karboksamidijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältäviä lääkekoostumuksia
FI970455A7 (fi) 8-fluori-antrasykliinejä, menetelmä niiden valmistamiseksi ja niitä si sältäviä farmaseuttisia koostumuksia

Legal Events

Date Code Title Description
PC4A Assignment and transfer of rights

Owner name: PAH USA 15 LLC, NEW YORK, US

Free format text: FORMER OWNER: PFIZER PRODUCTS INC., GROTON, CT, US

Effective date: 20130703

SPCT Transfer of rights of an spc

Owner name: ZOETIS P LLC, US

Free format text: FORMER OWNER: PFIZER PRODUCTS INC., US

Spc suppl protection certif: 20 5001-2005

Effective date: 20121001

TC4A Change of owner's name

Owner name: ZOETIS P LLC, FLORHAM PARK, NEW JERSEY, US

Effective date: 20130704

PC4A Assignment and transfer of rights

Owner name: ZOETIS SERVICES LLC, FLORHAM PARK, NJ, US

Free format text: FORMER OWNER: ZOETIS P LLC, FLORHAM PARK, NEW JERSEY, US

Effective date: 20151012

SPCC Change of address or name of an owner of an spc

Owner name: ZOETIS SERVICES LLC, US

Spc suppl protection certif: 20 5001-2005

Effective date: 20170314

TE4A Change of owner's address

Owner name: ZOETIS SERVICES LLC, PARSIPPANY, NEW JERSEY, US

Effective date: 20170314

MK4A Patent expired

Expiry date: 20180529

SPCE Expiry of an spc

Spc suppl protection certif: 20 5001-2005

Effective date: 20181113